<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=442589386215482&amp;ev=PageView&amp;noscript=1">
Logo no 7 days Master Eye Associates-Transparency Better Size
Schedule Online

Avastin Central Retina Macular Degeneration Treatment Lucentis Macular Degeneration Macula Eylea Aflibercept

EYLEA is a New Medicine for the Treatment of Macular Degeneration

Eylea is an Effective Treatment for Macular Degeneration and Costs Less than Current Similar Medicine EYLEA™ (aflibercept) was approved in December 2011 for the treatment of neovascular (wet) macular degeneration. Eylea (by Regeneron) works much like Lucentis and Avastin in its treatment of macular degeneration except that it is used less frequently and costs less. The recommended dose for EYLEA is 2 mg (0.05 mL) administered by injection into the vitreous of the eye every 4 weeks (monthly) for the first 3 months followed by 2 mg (0.05 mL) via injection once every 8 weeks (2 months).
Read More
All posts

About Eye Care News

Eye Care News features important topics regarding eye care health.  Over one-hundred eye care posts have been published, providing our readers with a great resource for timely news about eye care.

Subscribe to Email Updates

Our Most Popular Posts

Posts by Topic

see all

Recent Posts

Master Eye Associates

Eye Care Resources

Contact Us
Master Eye Associates Facebook Master Eye Associates Google Plus Master Eye Associates Twitter Master Eye Associates YouTube

DISCLAIMER: The information on this website is for educational purposes only. The information on this website is not meant to diagnose or treat any disease(s). Only a licensed doctor can diagnose or treat disease. No information on this website has been evaluated by the U.S. Food and Drug Administration.
© 2023 Master Eye Associates